A-FABP - A biomarker associated with the metabolic syndrome and/or an indicator of weight change?

Obesity

Volumn 16, Issue 8, 2008, Pages 1838-1842

  Engl, Julia ^a   Ciardi, Christian ^a   Tatarczyk, Tobias ^a   Kaser, Susanne ^a   Laimer, Markus ^a   Laimer, Elisabeth ^b   Weiss, Helmut ^b   Aigner, Franz ^b   Molnar, Clemens ^a   Tilg, Herbert ^b   Patsch, Josef R ^a   Ebenbichler, Christoph F ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^b INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; FATTY ACID BINDING PROTEIN; LIPID;

ADULT; ARTICLE; BARIATRIC SURGERY; BLOOD; BODY COMPOSITION; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; HUMAN; METABOLIC SYNDROME X; METABOLISM; MIDDLE AGED; MORBID OBESITY; PATHOPHYSIOLOGY; PHYSIOLOGY; WEIGHT REDUCTION;

ADULT; BARIATRIC SURGERY; BIOLOGICAL MARKERS; BLOOD GLUCOSE; BODY COMPOSITION; FATTY ACID-BINDING PROTEINS; FEMALE; FOLLOW-UP STUDIES; HUMANS; LIPIDS; METABOLIC SYNDROME X; MIDDLE AGED; OBESITY, MORBID; WEIGHT LOSS;

EID: 48749123067     PISSN: 19307381     EISSN: 1930739X     Source Type: Journal    
DOI: 10.1038/oby.2008.273     Document Type: Article

References (29)

1. Haunerland NH, Spener F. Fatty acid-binding proteins - insights from genetic manipulations. Prog Lipid Res 2004;43:328-349.
2. Makowski L, Hotamisligil GS. Fatty acid binding proteins - the evolutionary crossroads of inflammatory and metabolic responses. J Nutr 2004;134:2464S-2468S.
3. Makowski L, Boord JB, Maeda K et al. Lack of macrophage fatty-acid-binding protein aP2 protects mice deficient in apolipoprotein E against atherosclerosis. Nat Med 2001;7:699-705.
4. Boord JB, Maeda K, Makowski L et al. Combined adipocyte-macrophage fatty acid-binding protein deficiency improves metabolism, atherosclerosis, and survival in apolipoprotein E-deficient mice. Circulation 2004;110:1492-1498.
5. Uysal KT, Scheja L, Wiesbrock SM et al. Improved glucose and lipid metabolism in genetically obese mice lacking aP2. Endocrinology 2000;141:3388-3396.
6. Hotamisligil GS, Johnson RS, Distel RJ et al. Uncoupling of obesity from insulin resistance through a targeted mutation in aP2, the adipocyte fatty acid binding protein. Science 1996;274:1377-1379.
7. Makowski L, Brittingham KC, Reynolds JM, Suttles J, Hotamisligil GS. The fatty acid-binding protein, aP2, coordinates macrophage cholesterol trafficking and inflammatory activity. Macrophage expression of aP2 impacts peroxisome proliferator-activated receptor gamma and IkappaB kinase activities. J Biol Chem 2005;280:12888-12895.
8. Xu A, Wang Y, Xu JY et al. Adipocyte fatty acid-binding protein is a plasma biomarker closely associated with obesity and metabolic syndrome. Clin Chem 2006;52:405-413.
9. Stejskal D, Karpisek M. Adipocyte fatty acid binding protein in a Caucasian population: a new marker of metabolic syndrome? Eur J Clin Invest 2006;36:621-625.
10. Sandhofer A, Kaser S, Ritsch A et al. Cholesteryl ester transfer protein in metabolic syndrome. Obesity (Silver Spring) 2006;14:812-818.
11. Laimer M, Ebenbichler CF, Kaser S et al. Markers of chronic inflammation and obesity: a prospective study on the reversibility of this association in middle-aged women undergoing weight loss by surgical intervention. Int J Obes Relat Metab Disord 2002;26:659-662.
12. Laimer M, Kaser S, Kranebitter M et al. Effect of pronounced weight loss on the nontraditional cardiovascular risk marker matrix metalloproteinase-9 in middle-aged morbidly obese women. Int J Obes (Lond) 2005;29:498-501.
13. Sandhofer A, Laimer M, Ebenbichler CF et al. Soluble leptin receptor and soluble receptor-bound fraction of leptin in the metabolic syndrome. Obes Res 2003;11:760-768.
14. Ebenbichler CF, Laimer M, Kaser S et al. Relationship between cholesteryl ester transfer protein and atherogenic lipoprotein profile in morbidly obese women. Arterioscler Thromb Vasc Biol 2002;22:1465-1469.
15. Kaser S, Laimer M, Sandhofer A et al. Effects of weight loss on PLTP activity and HDL particle size. Int J Obes Relat Metab Disord 2004;28:1280-1282.
16. Engl J, Bobbert T, Ciardi C et al. Effects of pronounced weight loss on adiponectin oligomer composition and metabolic parameters. Obesity (Silver Spring) 2007;15:1172-1178.
17. Forsell P, Hallberg D, Hellers G. Gastric banding for morbid obesity: initial experience with a new adjustable band. Obes Surg 1993;3:369-374.
18. Mittermair RP, Aigner F, Nehoda H. Results and complications after laparoscopic adjustable gastric banding in super-obese patients, using the Swedish band. Obes Surg 2004;14:1327-1330.
19. Mittermair RP, Weiss H, Nehoda H et al. Laparoscopic Swedish adjustable gastric banding: 6-year follow-up and comparison to other laparoscopic bariatric procedures. Obes Surg 2003;13:412-417.
20. Nehoda H, Weiss H, Labeck B et al. Results and complications after adjustable gastric banding in a series of 250 patients. Am J Surg 2001;181:12-15.
21. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972;18:499-502.
22. Matthews DR, Hosker JP, Rudenski AS et al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28:412-419.
23. Engl J, Hanusch-Enserer U, Prager R, Patsch JR, Ebenbichler C. Wien Klin Wochenschr 2005;117:243-54.
24. Zimmermann R, Strauss JG, Haemmerle G et al. Fat mobilization in adipose tissue is promoted by adipose triglyceride lipase. Science 2004;306:1383-1386.
25. Shen WJ, Liang Y, Hong R et al. Characterization of the functional interaction of adipocyte lipid-binding protein with hormone-sensitive lipase. J Biol Chem 2001;276:49443-49448.
26. Carmen GY, Victor SM. Signalling mechanisms regulating lipolysis. Cell Signal 2006;18:401-408.
27. Arner P. Insulin resistance in type 2 diabetes: role of fatty acids. Diabetes Metab Res Rev 2002;18(Suppl 2):S5-S9.
28. Pelsers MM, Hanhoff T, Van der, Voort D et al. Brain- and heart-type fatty acid-binding proteins in the brain: tissue distribution and clinical utility. Clin Chem 2004;50:1568-1575.
29. Pelsers MM, Hermens WT, Glatz JF. Fatty acid-binding proteins as plasma markers of tissue injury. Clin Chim Acta 2005;352:15-35.